We examined whether endogenous hydrogen peroxide (H 2 O 2 ) is involved in pacing-induced metabolic vasodilation in vivo.
Conclusions
Cardiac tachycardia by pacing or exercise increases myocardial oxygen consumption (MVO 2 ) and increases coronary blood flow by several mechanisms (1) (2) (3) . Shear stress plays a crucial role in modulating vascular tone by endotheliumderived releasing factors (EDRFs), including nitric oxide (NO), prostacyclin (PGI 2 ), and endothelium-derived hyperpolarizing factor (EDHF) (4, 5) . Flow-induced vasodilation is mediated by either NO (6,7), PGI 2 (8) , both of them (9) , or EDHF (10 primary EDHF in mesenteric arteries of mice and humans (11, 12) . Morikawa et al. (13, 14) subsequently confirmed that endothelial Cu,Zn-superoxide dismutase (SOD) plays an important role as an EDHF synthase in mice and humans. Miura et al. (15) demonstrated that endotheliumderived H 2 O 2 is involved as an EDHF in the flow-induced vasodilation of isolated human coronary arterioles in vitro. We have recently confirmed that endogenous H 2 O 2 plays an important compensatory role during coronary autoregulation (16) and reperfusion injury in vivo (17) through the interactions with NO and adenosine.
It is known that vascular ␣-adrenergic receptor is modulated by the endothelium in dogs (18) , whereas cardiac ␤-adrenergic receptor is modulated by K Ca channels in pigs (19) and H 2 O 2 in mice (20) . However, the role of endogenous H 2 O 2 in metabolic coronary vasodilation in vivo remains largely unknown. In the present study, we thus examined whether H 2 O 2 is involved in pacing-induced metabolic coronary vasodilation in canine coronary microcirculation in vivo.
Methods
This study conformed to the Guideline on Animal Experiments of Kawasaki Medical School and the Guide for the Care and Use of Laboratory Animals published by the U.S. National Institutes of Health. Animal preparation. Anesthetized mongrel dogs of either gender (15 to 25 kg in body weight, n ϭ 60) were ventilated with a ventilator (Model VS600, IDC, Pittsburgh, Pennsylvania). We continuously monitored aortic pressure and left ventricular pressure (LVP) with a catheter (SPC-784A, Millar, Houston, Texas) and blood flow of the left anterior descending coronary artery (LAD) with a transonic flow probe (T206, Transonic Systems, Ithaca, New York). Measurements of coronary diameter by intravital microscope. We continuously monitored coronary vascular responses by an intravital microscope (VMS 1210, Nihon Kohden, Tokyo, Japan) with a needle-probe in vivo, as previously described (21) . We gently placed the needleprobe on subepicardial microvessels. When a clear vascular image was obtained, end-diastolic vascular images were taken with 30 pictures/s (21) . Measurements of regional myocardial blood flow. Regional myocardial blood flow was measured by the nonradioactive microsphere (Sekisui Plastic Co. Ltd., Tokyo, Japan) technique, as previously described (22) . Briefly, the microspheres suspension was injected into the left atrium 3 min after tachypacing. Myocardial flow in the LAD area was calculated according to the formula "time flow ϭ tissue counts ϫ (reference flow/reference counts)" and was expressed in ml/g/min (22) . Detection of H 2 O 2 and NO production in coronary microvessels. 2=,7=-dichlorodihydrofluorescein diacetate (DCF) (Molecular Probes, Eugene, Oregon) and diaminorhodamine-4M AM (DAR) (Daiichi Pure Chemicals, Tokyo, Japan) were used to detect H 2 O 2 and NO production in coronary microvessels, respectively, as previously described (17) . Briefly, fresh and unfixed heart tissues were cut into several blocks and immediately frozen in optimal cutting temperature compound (Tissue-Tek, Sakura Fine Chemical, Tokyo, Japan). Fluorescent images of the microvessels were obtained 3 min after application of acetylcholine (ACh) by using a fluorescence microscope (OLYMPUS BX51, Tokyo, Japan) (17) . Experimental protocols. After the surgical procedure and instrumentation, at least 30 min were allowed for stabilization while monitoring hemodynamic variables. Coronary vasodilator responses were examined before and after cardiac tachypacing (60 to 120 beats/min) under the following 7 conditions with cyclooxygenase blockade (ibuprofen, 12.5 mg/kg, IV) to evaluate the role of H 2 O 2 and NO without PGI 2 in a different set of animals ( . These inhibitors were given at 30 min before cardiac tachypacing (Fig. 1 ). The basal coronary diameter was defined as that before pacing. We continuously observed the diameter change in subepicardial small coronary arteries (Ն100 m) and arterioles (Ͻ100 m) with an intravital microscope before and at 2 min after pacing. Microspheres were administered at 3 min after the pacing was started (Fig. 1 ). In the combined infusion protocol (L-NMMAϩcatalaseϩ8-SPT), L-NMMA infusion was first started, followed by catalase infusion, and then 8-SPT was added at 15 min after the initiation of L-NMMA infusion (Fig. 1) . Then, fresh and unfixed heart tissues were cut into several blocks and immediately frozen in optimal cutting temperature compound after the pacing. The flow and MVO 2 were measured as full-thickness values.
Drugs. All drugs were obtained from Sigma Chemical Co. and were diluted in a physiological saline immediately before use. Statistical analysis. Results are expressed as means Ϯ SEM. Differences in the vasodilation of subepicardial coronary microvessels before and after pacing (Fig. 2) were examined by a multiple regression analysis using a model, in which the change in coronary diameter was set as a dependent variable (y) and vascular size as an explanatory variable (x), while the statuses of control and other inhibitors were set as dummy variables (D1, D2) in the following equation: y ϭ a0 ϩ a1x ϩ a2D1 ϩ a3D2, where a0 through a3 are partial regression coefficients (16) . Significance tests were made as simultaneous tests for slope and intercept differences. Pairwise comparisons against control were made without adjustment for multiple comparisons. The vessel was the unit of analysis without correction for correlated observations. The power of this analysis is greater than that of using the animal as the unit of analysis, giving smaller p values. Vascular fluorescent responses (Figs. 3 and 4) were analyzed by one-way analysis of variance followed by Scheffe's post hoc test for multiple comparisons. The criterion for statistical significance was at p Ͻ 0.05.
Results

Hemodynamic status and blood gases during pacing.
Throughout the experiments, mean aortic pressure was constant and comparable (Table 1) , and pO 2 , pCO 2 , and pH were maintained within the physiological ranges (pO 2 Ͼ70 mm Hg, pCO 2 25 to 40 mm Hg, and pH 7.35 to 7.45). Baseline coronary diameter was comparable in the absence and presence of inhibitors under the 7 different experimental conditions (Table 1) . Cardiac tachypacing increased coronary blood flow and MVO 2 from the baseline values (Table 2, 
bined infusion of L-NMMAϩcatalase or L-NMMAϩ TEA significantly decreased CBF (both p Ͻ 0.05) and MVO 2 (both p Ͻ 0.05) as compared with control after the pacing.
Coronary vasodilation before and after cardiac tachypacing. Cardiac tachypacing caused coronary vasodilation in both-sized arteries under control conditions (small coronary arteries, 5 Ϯ 1%; arterioles, 14 Ϯ 2%) ( Fig. 2A) with decreased coronary venous pO 2 ( Table 2 ). The metabolic coronary vasodilation was significantly decreased after L-NMMA in small coronary arteries (3 Ϯ 1%) but not in arterioles (14 Ϯ 2%), whereas catalase and 8-SPT decreased the vasodilation of arterioles (both 4 Ϯ 1%) but not in small coronary arteries (both 7 Ϯ 1%) (Figs. 2B and 2C) . Furthermore, the metabolic coronary vasodilation was markedly attenuated after L-NMMAϩcatalase and L-NMMAϩTEA in small coronary arteries (both 2 Ϯ 1%), and L-NMMAϩcatalaseϩ8-SPT almost abolished the vasodilating responses in both-sized arteries (small coronary arteries, Ϫ1 Ϯ 1%; arterioles, 1 Ϯ 1%) (Figs. 2D to 2F ). When expressed in a linear regression analysis, the coronary vasodilating responses of both-sized coronary arteries were significantly inhibited in all experimental conditions except L-NMMA alone ( Fig. 2A ). (Fig. 3 ). The pacing-induced H 2 O 2 production as assessed by DCF fluorescent intensity was unaltered after L-NMMA but was markedly suppressed by catalase (Fig. 3) . By contrast, in small coronary arteries, vascular NO production as assessed by DAR fluorescent intensity was significantly increased in response to the pacing compared with baseline conditions (Fig. 4) . The pacinginduced NO production was unaltered after catalase but was markedly suppressed by L-NMMA (Fig. 4) . Pacing caused no significant increase in H 2 O 2 production in small coronary arteries or NO production in arterioles (data not shown).
Discussion
The major finding of the present study is that endogenous Rest (m)
Results are expressed as mean Ϯ SEM. *p Ͻ 0.01, †p Ͻ 0.05 versus rest. L-NMMA ϭ N G -monomethyl-L-arginine; SPT ϭ sulfophenyltheophylline; TEA ϭ tetraethylammonium. (13) and human (14) mesenteric arteries. Subsequently, we (16, 17) and others (15) confirmed that endogenous H 2 O 2 exerts important vasodilator effects in canine coronary microcirculation in vivo and in isolated human coronary microvessels, respectively. In the present study, the pacing-induced metabolic coronary vasodilation was significantly decreased after L-NMMA in small coronary arteries but not in arterioles, whereas catalase decreased the vasodilation of arterioles but not that of small arteries, and the coronary vasodilation was markedly attenuated after L-NMMAϩcatalase (Fig. 2) Ϫ that is formed during mitochondrial electron transport, is seminal in the coupling between oxygen metabolism and blood flow in the heart. Thus, the contribution of H 2 O 2 production in response to the change in metabolism cannot be excluded.
Hemodynamic Status at Rest and During Cardiac Pacing
Endothelial Cu,Zn-SOD plays an important role in the synthesis of H 2 O 2 as an EDHF synthase in mouse (13) and human (14) mesenteric arteries, and exercise training enhances expression of Cu,Zn-SOD in normal pigs (26) . It remains to be examined whether exercise-induced upregulation of Cu,Zn-SOD enhances metabolic coronary vasodilation mediated by endogenous H 2 O 2 . Compensatory vasodilator mechanism among H 2 O 2 , NO, and adenosine. The EDHF acts as a partial compensatory mechanism to maintain endothelium-dependent vasodilation in the forearm microcirculation of patients with essential hypertension, where NO activity is impaired owing to oxidative stress (27) . We have recently demonstrated in the fluorescent microscopy study that coronary vascular production of H 2 O 2 and NO is enhanced after myocardial ischemia/reperfusion in small coronary arteries and arterioles, respectively (17) . In the present study, the DCF fluorescent intensity was comparable between control and L-NMMA, and that of DAR was also comparable between control and catalase (Figs. 3 and 4) . Although the exact source of vascular production of H 2 O 2 and NO remains to be elucidated, it is highly possible that endothelium-derived NO and H 2 O 2 compensate for each other to maintain coronary vasodilation in response to increased MVO 2 .
In the dog, blockade of any vasodilator mechanisms fails to blunt the increase in coronary blood flow in response to exercise, indicating that adenosine, K ϩ ATP -channel opening, prostanoids, or NO might not be mandatory for exercise-induced coronary vasodilation, or that these redundant vasodilator mechanisms compensate for each other when one mechanism is blocked (28) . In the present study, adenosine blockade with 8-SPT alone inhibited the pacinginduced vasodilation of arteriole but not that of small artery, whereas combined administration of L-NMMAϩcatalaseϩ8-SPT almost abolished the pacing-induced coronary vasodilation of both-sized arteries with an increase in coronary blood flow (Fig. 2) . The discrepancy between the diameter and flow responses is likely due to the metabolic autoregulation of smaller arterioles. These results indicate that adenosine also plays an important role to maintain metabolic coronary vasodilation in cooperation with NO and H 2 O 2 , a finding consistent with our previous study on coronary autoregulatory mechanisms (15) . Study limitations. Several limitations should be mentioned for the present study. First, although we were able to demonstrate the production of H 2 O 2 with fluorescent microscopy with DCF, we were unable to quantify the endothelial H 2 O 2 production, because DCF reacts with H 2 O 2 , peroxynitrite, and hypochlorous acid (13) . Second, we were unable to find smaller arterioles, owing to the limited spatial resolution of our charge-coupled device intravital microscope. With an intravital camera with higher resolution, we would be able to observe coronary vasodilation of smaller arterioles. Third, we were unable to determine whether H 2 O 2 is produced by shear stress or cardiac metabolism. This point remains to be elucidated in a future study.
